Nuvectis Pharma (NASDAQ:NVCT) lost ~45% on Thursday after the oncology-focused biotech announced data from an ongoing ...

Researchers from the Walter and Eliza Hall Institute (WEHI)in Australia have found a new way to predict a subset of patients ...

A University of Iowa researcher is using federal funding to develop a new approach to combat ovarian cancer. According to the ...

Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...

Researchers found significant differences in ovarian cancer survival among Asian American subgroups, emphasizing the ...

University of Iowa researchers have landed a $10-million federal grant to develop a new treatment for ovarian cancer. Jill ...

Researchers discovered that ovarian tumors hinder T cells' energy supply by trapping a key protein, blocking lipid uptake. A ...

CERo Therapeutics stock is rising higher on Monday as investors react to the latest preclinical data concerning lead compound ...

Followed categories will be added to My News. In a world-first finding, Melbourne researchers investigated a major “blind ...

Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way that ovarian cancer tumors manipulate their ...

The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

CERo Therapeutics (CERO) announces the presentation of preclinical data demonstrating the capability of its lead compound CER-1236 to kill ...